Breakthrough: INSPIRIS RESILIA Aortic Valve Gets FDA Approval
Edwards Releases 5-Year RESILIA Tissue Aortic Valve Study Data | Medical Product Outsourcing
Help Your Severe Aortic Stenosis Patients with Collaboration from a Multidisciplinary Heart Valve Team | HeartValves
Edward's Inspiris Resilia Valve Receives FDA Approval
INSPIRIS Resilia
First procedures using Edward Lifesciences' Inspiris Resilia aortic valve take place - Cardiovascular News
INSPIRIS RESILIA Aortic Valve | Edwards Lifesciences
Breakthrough: INSPIRIS RESILIA Aortic Valve Gets FDA Approval
5-Year COMMENCE Data Show Continued Promise for Novel Valve Tissue in SAVR – Consult QD
Long-term durability of a new surgical aortic valve: A 1 billion cycle in vitro study - ScienceDirect
INSPIRIS Resilia
JCM | Free Full-Text | Perimount MAGNA Ease vs. INSPIRIS Resilia Valve: A PS-Matched Analysis of the Hemodynamic Performances in Patients below 70 Years of Age
INSPIRIS RESILIA Aortic Valve | Edwards Lifesciences
Edwards' Aortic Valve With Resilia Tissue Shows Favorable Durability, Safety and Efficacy Outcomes in Seven Year Data
Long-term durability of a new surgical aortic valve: A 1 billion cycle in vitro study - ScienceDirect
YourTissueValve
Perioperative and Echocardiographic Considerations for the Inspiris Resilia Aortic Valve--Current and Future - Journal of Cardiothoracic and Vascular Anesthesia
Edward's Inspiris Resilia Valve Receives FDA Approval
Mechanical versus bioprosthetic valves for severe aortic stenosis
Edwards Lifesciences wins CE Mark for Inspiris Resilia aortic valve - MassDevice
Breakthrough: INSPIRIS RESILIA Aortic Valve Gets FDA Approval
Edwards Lifesciences wins FDA approval for Inspiris Resilia valve - MassDevice
